Epub ahead of print

Bell RJ, Fradkin P, Robinson PJ, Schwarz M, Davis SR. Intended follow-up of women with breast cancer at low risk of recurrence and at least 5 years from diagnosis. Intern Med J 2013 June 5 [epub ahead of press]

Davis SR. Reproductive endocrinology: Hormone therapy to treat menopause-breaking a taboo. Nat Rev Endocrinol. 2013 Oct 29. doi: 10.1038/nrendo.2013.219. [Epub ahead of print]

Davis SR, Davison SL, Gavrilescu M, Searle K, Gogos A, Rossell SL, Egan GF, Bell RJ. Effects of testosterone on visuospatial function and verbal fluency in postmenopausal women: results from a functional magnetic resonance imaging pilot study. Menopause. 2013 Sep 2. [Epub ahead of print]

Davis SR, Bitzer J, Giraldi A, Palacios S, Parke S, Serrani M, Mellinger U, Nappi RE. Change to Either a Nonandrogenic or Androgenic Progestin-Containing Oral Contraceptive Preparation is Associated with Improved Sexual Function in Women with Oral Contraceptive-Associated Sexual Dysfunction. J Sex Med. 2013 Sep 12. doi: 10.1111/jsm.12310. [Epub ahead of print]

Davis SR, Worsley R. Androgen Treatment of postmenopausal women. J Steroid Biochem Mol Biol 2013 May [Epub ahead of print]

Bell RJ, Robinson PJ, Nazeem F, Panjari M, Fradkin P, Schwarz M, Davis SR. Persistent breast pain 5 years after treatment of invasive breast cancer is largely unexplained by factors associated with treatment. J Cancer Surviv. 2013 Aug 23. [Epub ahead of print]

Gartoulla P, Islam MR, Bell RJ, Davis SR. Prevalence of menopausal symptoms in Australian women at midlife: a systemic review. Climacteric 2013 Nov 18 [Epub ahed of print]

Davis SR. Hormone therapy to treat menopause-breaking the taboo. Nature Rev Endocrinology.

Research articles

Bell RJ, Fradkin P, Schwarz MA, Davis SR. Understanding discontinuation of oral adjuvant endocrine therapy by women with hormone receptor-positive invasive breast cancer nearly 4 years from diagnosis. Menopause 2013 vol 20, issue 1, 15-21

Bell RJ, Robinson PJ, Barallon R, Fradkin P, Schwarz MA, Davis SR. Lymphedema: experience of a cohort of women with breast cancer followed for 4 years after diagnosis in Victoria, Australia, Supportive Care In Cancer 2013 vol 21, issue 7 2017-2024

Bell RJ, Schwarz MA, Fradkin P, Davis SR. Use of imaging in surveillance of women with early stage breast cancer, ANZ Journal of Surgery 2013, vol 83, issue 3, 129-134.

Bell RJ, Schwarz MA, Fradkin P, Robinson PJ, Davis SR. Patterns of use of oral adjuvant endocrine therapy in Australian breast cancer survivors 5 years from diagnosis, Menopause 2013 vol 20, issue 7. 721-726

Davies C, Pan H, Godwin J, Gray R, Arriagada R, Rains V, Raina V, Abraham M, Alencar VHM, Badran A, Bonfill Cosp X, Bradbury JC, Clarke M, Collins R, Davis SR, Delmestri A, Forbes J, Haddad P, Hou M, Inbar M, Khaled H, Kielanowska J, Kwan W, Mathew B, Muller B, Nicolucci A, Peralta O, Pernas F, Pienkowski T, Petruzelka L, Rajan B, Rubach M, Tort S, Urrutia G, Valentini M, Wang Y, Peto R. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial, Lancet 2013 vol 381, (9869):805-816. [Epub 5th December 2012]

Robinson PJ, Lanzafame A, Segal L, Kirby CN, Piterman L, Davis SR. 2013. Comparison of plain vertebral x-ray and dunal energy x-ray absorptiometry for the identification of older women for fracture prevention in primary care, Internal Medicine Journal [P], vol 43, issue 1, Wiley-Blackwell Publishing Asia, Australia, pp. 38-45

Worsley R, Robinson PJ, Bell RJ, Moufarege A, Davis SR. 2013, Endogenous estrogen and androgen levels are not independent predictors of lipid levels in postmenopausal women, Menopause 2013 vol 20, issue 6, Lippincott Williams & Wilkins, Philadelphia, United States, pp. 640-645

Davison SL, Bell RJ, Robinson PJ, Jane F, Leech J, Maruff P, Egan GF, Davis SR. Continuous-combined oral estradiol/drospirenone has no detrimental effect on cognitive performance and improves estrogen deficiency symptoms in early postmenopausal women: a randomized placebo-controlled trial. Menopause. 2013 Oct;20(10): 1020-1026

Robinson PJ, Bell RJ, Lanzafame A, Kirby C, Weekes A, Piterman L, Davis SR. The prevalence of vitamin D deficiency and relationship with fracture risk in older women presenting in Australian general practice. Australas J Ageing. 2013 Sep;32(3):177-83

Bell RJ, Fradkin P, Parathithasan N, Robinson P, Schwarz M, Davis SR. Pregnancy-associated breast cancer and pregnancy following treatment for breast cancer, in a cohort of women from Victoria, Australia, with a first diagnosis of invasive breast cancer. The Breast 2013 Oct;22(5):980-985

Review Articles

De Villiers T, Pines A, Panay N, Gambacciani MM, Archer DF, Baber R, Davis SR, Gompel A, Henderson VW, Langer R, Lobo RA, Plu-Bureau G, Sturdee DW. 2013, Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health, Climacteric [P], vol 16, issue 3, Informa Healthcare, United Kingdom, pp. 316-337

Jane FM, Davis SR. 2013, Perimenopause: a time of change, Medicine Today [P], vol 14, issue 3, Medicine Today Pty Ltd, Australia, pp. 27-32.

Jane F, Davis SR. Navigating the menopause. Medicine Today 2013 14(1): 37-42

Davis SR. Androgen use for low sexual desire in midlife women. 2013 Menopause vol 20, (7): 795-797

Burton R, Bell R. The global challenge of reducing breast cancer mortality. The Oncologist 2013 18:1200-1202
24. Davis SR. Androgen therapy in women, beyond libido. Climacteric. 2013 16(Suppl 1):18


Davis SR, Robinson PJ, Bell RJ. Letter in reply. Urinary Incontinence in young nulligravid women. Ann Int Med 2013 158(2): 139